Just finished reading "Dancing at the edge" an exploration of competencies for the 21st century. An excellent and academic
Just finished reading "Dancing at the edge" an exploration of competencies for the 21st century. An excellent and academic review of the topic giving hope that "future persons" will indeed be more resilient. Instead of simply listing competencies they describe examples from the extensive range of interviews...
Source: internationalfuturesforum.com
The rise of the robots Excellent read but of a gloomy dystopian future where robots and software take over manual tasks
The rise of the robots
Excellent read but of a gloomy dystopian future where robots and software take over manual tasks (as they already have done) and also skilled labour displacing even highly skilled jobs in time. Healthcare might survive a little longer but physicians assistants empowered by...
Source: amazon.co.uk
Large-Scale Solar and Repurposed EV Batteries to Play Large Role in California's Renewable Energy Future: In October, California
Large-Scale Solar and Repurposed EV Batteries to Play Large Role in California's Renewable Energy Future: In October, California passed a bill requiring the state to get half of its electricity from renewables by 2030
Source: ieee.org
The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines: This Viewpoint discusses the
The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines: This Viewpoint discusses the importance of patent protection and its role in the Trans-Pacific Partnership (TPP) Agreement. Jing Luo. Aaron S. Kesselheim. JAMA.
Source: jamanetwork.com
Infographic on microlearning - e-Learning Feeds: Over the past few months, in Snackson we have specialized in how to apply
Infographic on microlearning - e-Learning Feeds: Over the past few months, in Snackson we have specialized in how to apply microlearning in organizations effectively. Thanks to this task and the studies m
Source: elearningfeeds.com
Sanofi wins EU approval for Praluent anti-cholesterol drug: French drugmaker Sanofi said the European Commission had cleared
Sanofi wins EU approval for Praluent anti-cholesterol drug: French drugmaker Sanofi said the European Commission had cleared its key cholesterol drug Praluent for the treatment of so-called "bad cholesterol," or low-density lipoprotein (LDL) cholesterol, in certain adult patients with hypercholesterolemia.
Source: reuters.com
RSS feed